University of California, Berkeley at IDWeek 2026
Oct 21–24, 2026 Washington, DC ~12k attendees Website
University of California, Berkeley brings 2 presentations to IDWeek 2026 in Washington. Its program spans adult respiratory vaccines and prevention of sexually transmitted infections. It estimates the direct and indirect effects of doxycycline post-exposure prophylaxis on chlamydia and gonorrhea, and joins Stanford University and Pfizer on real-world vaccine evidence.
| Organization | IDWeek 2026 Attendance |
|---|---|
University of California, Berkeley Berkeley, CA | |
Industry Thu Oct 22 7:00am–8:00am Real-World Evidence on Adult Respiratory Vaccines and Select Acute and Post-Acute Outcomes Associated With Respiratory Infections VaccinesRespiratory infections and COVID-19 Talk Sat Oct 24 1:45pm–2:00pm Estimating Direct and Indirect Effects of Doxycycline Post-Exposure Prophylaxis on Chlamydia and Gonorrhea Among MSM and Non-MSM Individuals in Southern California: A Retrospective Observational Study HIV, sexually transmitted infections and viral hepatitis |
Instantly find 20 buyers from University of California, Berkeley
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction